Overexpression of dihydrofolate reductase is a factor of poor survival in acute lymphoblastic leukemia

Dihydrofolate reductase (DHFR) has an important function in DNA synthesis and is a target of methotrexate, which is a crucial treatment option for acute lymphoblastic leukemia (ALL). However, the number of studies conducted to date on DHFR expression in childhood ALL is limited. The aim of the prese...

Descripción completa

Detalles Bibliográficos
Autores principales: Organista-Nava, Jorge, Gómez-Gómez, Yazmín, Illades-Aguiar, Berenice, Rivera-Ramírez, Ana Bertha, Saavedra-Herrera, Mónica Virginia, Leyva-Vázquez, Marco Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950508/
https://www.ncbi.nlm.nih.gov/pubmed/29805575
http://dx.doi.org/10.3892/ol.2018.8429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950508/
https://www.ncbi.nlm.nih.gov/pubmed/29805575
http://dx.doi.org/10.3892/ol.2018.8429

Ejemplares similares